MDT vs MMM
Medtronic PLC and 3M Co., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | MDT | MMM |
|---|---|---|
| Revenue | $36.4B | $24.9B |
| Net income | $4.8B | $3.2B |
| Gross margin | 65.0% | 39.9% |
| Net margin | 13.3% | 13.1% |
| Return on equity | 9.8% | 76.1% |
| Diluted EPS | $3.73 | $6.00 |
| Dividend / share | $2.84 | $2.92 |
| Payout ratio | 75.8% | 48.1% |
| Free cash flow | $5.4B | $1.4B |
| Equity | $49.5B | $4.7B |
| Net debt / equity | 0.53× | 1.57× |
| Current ratio | 2.13× | 1.71× |
| Revenue CAGR 5y | 3.8% | −5.0% |
| Profit CAGR 5y | 5.9% | −9.8% |
MDT bills 1.5× the revenue of MMM, and keeps more of each dollar of revenue as profit (13.3% against 13.1%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
10 years side by side
| Fiscal year | MDT | MMM |
|---|---|---|
| FY2025 | $36.4B | $24.9B |
| FY2024 | $33.5B | $24.6B |
| FY2023 | $32.4B | $24.6B |
| FY2022 | $31.2B | $26.2B |
| FY2021 | $31.7B | $35.4B |
| FY2020 | $30.1B | $32.2B |
| FY2019 | $28.9B | $32.1B |
| FY2018 | $30.6B | $32.8B |
| FY2017 | $30.0B | $31.7B |
| FY2016 | $29.7B | $30.1B |
Bottom line
| Fiscal year | MDT | MMM |
|---|---|---|
| FY2025 | $4.8B | $3.2B |
| FY2024 | $4.7B | $4.2B |
| FY2023 | $3.7B | $-7.0B |
| FY2022 | $3.8B | $5.8B |
| FY2021 | $5.0B | $5.9B |
| FY2020 | $3.6B | $5.4B |
| FY2019 | $4.8B | $4.5B |
| FY2018 | $4.6B | $5.3B |
| FY2017 | $3.1B | $4.9B |
| FY2016 | $4.0B | $5.0B |
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$11,416,000,000 | MDT |
| FY2024 | +$8,962,000,000 | MDT |
| FY2023 | +$7,754,000,000 | MDT |
| FY2022 | +$5,066,000,000 | MDT |
| FY2021 | −$3,669,000,000 | MMM |
| FY2020 | −$2,067,000,000 | MMM |
| FY2019 | −$3,223,000,000 | MMM |
| FY2018 | −$2,208,000,000 | MMM |
| FY2017 | −$1,704,000,000 | MMM |
| FY2016 | −$399,000,000 | MMM |
| FY2015 | −$1,441,000,000 | MMM |
| FY2014 | −$11,560,000,000 | MMM |
| FY2013 | −$13,866,000,000 | MMM |
| FY2012 | −$13,314,000,000 | MMM |
The higher-revenue side has changed between MDT and MMM over this period. The gap has narrowed since the earliest year compared.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
14 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +0.2 pp | MDT |
| FY2024 | −3.1 pp | MMM |
| FY2023 | +39.8 pp | MDT |
| FY2022 | −10.0 pp | MMM |
| FY2021 | −0.8 pp | MMM |
| FY2020 | −4.9 pp | MMM |
| FY2019 | +2.5 pp | MDT |
| FY2018 | −1.2 pp | MMM |
| FY2017 | −5.0 pp | MMM |
| FY2016 | −3.3 pp | MMM |
| FY2015 | −3.7 pp | MMM |
| FY2014 | −2.5 pp | MMM |
| FY2013 | +2.7 pp | MDT |
| FY2012 | +5.8 pp | MDT |
The higher net margin has changed hands between MDT and MMM over this period.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
MMM's net margin has been more volatile than MDT's over the 14 comparable fiscal years — 11.6 percentage points of standard deviation against 2.8.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between MDT and MMM over these 14 fiscal years — MDT led in 5 and MMM in 9.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
MMM's return on equity has been more volatile than MDT's over the 14 comparable fiscal years — 35.5 percentage points of standard deviation against 3.5.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between MDT and MMM over these 14 fiscal years — MDT led in 1 and MMM in 13.
14 of 19 comparable fiscal years — a year missing data on either side is not counted.